Participating Faculty
Participating Faculty The contents of this supplement include 3 articles on comprehensive adrenergic blockage. This supplement has been reviewed by an expert in the field.
Disclosure Statement In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the editors/authors for this activity have completed conflict-of-interest disclosure statements. It is the policy of Preventive Medicine in Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. The following relationships have been disclosed: William T. Abraham, MD Speaker’s Bureau For/Research Grant From: GlaxoSmithKline
William T. Abraham, MD
Professor of Medicine Chief, Division of Cardiology The Ohio State University Columbus, Ohio Gregg C. Fonarow, MD
Associate Professor of Medicine Director, Ahmanson-UCLA Cardiomyopathy Center University of California, Los Angeles Los Angeles, California Michael B. Fowler, MB, FRCP
Gregg C. Fonarow, MD Speaker’s Bureau For/Research Grant From/Consultant To: Bristol-Myers Squibb GlaxoSmithKline Merck Pfizer
Professor of Medicine (Cardiovascular) Medical Director, Cardiomyopathy Center Stanford University Medical Center Stanford, California
Michael B. Fowler, MB, FRCP Speaker’s Bureau For/Research Grant From/Consultant To: AstraZeneca GlaxoSmithKline
Signed disclosures are on file at the offices of Preventive Medicine in Managed Care, Jamesburg, New Jersey.
VOL. 4, NO. 1, SUP. • PREVENTIVE MEDICINE IN MANAGED CARE •
S3
Disclosure Statement In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the editors/authors for this activity have completed conflict-of-interest disclosure statements. It is the policy of Preventive Medicine in Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. The following relationships have been disclosed: William T. Abraham, MD Speaker’s Bureau For/Research Grant From: GlaxoSmithKline
William T. Abraham, MD
Professor of Medicine Chief, Division of Cardiology The Ohio State University Columbus, Ohio Gregg C. Fonarow, MD
Associate Professor of Medicine Director, Ahmanson-UCLA Cardiomyopathy Center University of California, Los Angeles Los Angeles, California Michael B. Fowler, MB, FRCP
Gregg C. Fonarow, MD Speaker’s Bureau For/Research Grant From/Consultant To: Bristol-Myers Squibb GlaxoSmithKline Merck Pfizer
Professor of Medicine (Cardiovascular) Medical Director, Cardiomyopathy Center Stanford University Medical Center Stanford, California
Michael B. Fowler, MB, FRCP Speaker’s Bureau For/Research Grant From/Consultant To: AstraZeneca GlaxoSmithKline
Signed disclosures are on file at the offices of Preventive Medicine in Managed Care, Jamesburg, New Jersey.
VOL. 4, NO. 1, SUP. • PREVENTIVE MEDICINE IN MANAGED CARE •
S3
